Log In
Print
BCIQ
Print
Print this Print this
 

GAL-021

  Manage Alerts
Collapse Summary General Information
Company Galleon Pharmaceuticals Inc.
DescriptionUndisclosed small molecule designed to support respiratory drive in surgical and critical care patients
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationRespiratory distress syndrome (RDS)
Indication DetailsTreat respiratory depression
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today